Search

Your search keyword '"Germanium pharmacology"' showing total 120 results

Search Constraints

Start Over You searched for: Descriptor "Germanium pharmacology" Remove constraint Descriptor: "Germanium pharmacology"
120 results on '"Germanium pharmacology"'

Search Results

51. Effects of metallic antioxidants on cadmium-catalyzed peroxidation of arachidonic acid.

52. Organogermanium compounds as inhibitors of the activity of direct acting mutagens in Salmonella typhimurium.

53. Effect of pretreatment of germanium-132 on Na(+)-K(+)-ATPase and galactose cataracts.

54. Hazard assessment of germanium supplements.

55. [Experimental studies on effects of zinc and germanium on immune function and anti-oxidation in mice].

56. [Effects of selenium and germanium on lipid peroxidation in rats fed with low-selenium grain].

57. 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells.

58. Modifying role of trace elements on the mutagenicity of benzo[a]pyrene.

59. [Evaluation of health promotive effect of organometallic germanium compounds].

60. Effects of germanium and silicon on bone mineralization.

61. [The inhibition of the development of experimental tumors of the cervix uteri and vagina by using tinctures of the cultured-cell biomass of the ginseng root and its germanium-selective stocks].

62. Effects of 2-carboxythylgerumanium sesquioxide (Ge-132) as an immunological modifier of post-surgical immunosuppression in dogs.

63. [The characteristics of the action of the immunomodulator MOP-35 on macrophage 5'-nucleotidase activity depending on the time of day].

64. Inhibition by germanium oxide of the mutagenicity of cadmium chloride in various genotoxicity assays.

65. Germanium and silver resistance, accumulation, and toxicity in microorganisms.

66. [Effect of carboxyethylgermanium sesquioxide on cultured normal neonatal rat myocardial cells and cells injured by isoproterenol].

67. Decreased plasma superoxide scavenging activity in immunological disorders--carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone.

68. Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes.

69. Modifying responses of allyl sulfide, indole-3-carbinol and germanium in a rat multi-organ carcinogenesis model.

70. [A new inducer of immune interferon in human leukocytes--the organogermanium compound MOP-11].

71. Effects of proxigermanium on interferon production and 2',5'-oligoadenylate synthetase activity in the lung of influenza virus-infected mice and in virus-infected human peripheral blood mononuclear cell cultures.

72. [An analysis of the action of metalloatranes on the hypothalamic neurons of rats].

74. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound.

75. Antimutagenic effects of germanium oxide on Trp-P-2-induced frameshift mutations in Salmonella typhimurium TA98 and TA1538.

76. [Effect of isopropoxysilatrane and isopropoxygermatrane on connective tissue proliferative and reparative function].

77. [Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].

78. Inhibition of glutathione-S-aryltransferase from rat liver by organogermanium, lead and tin compounds.

79. [Effects of interferon and its inducers on neutrophil chemiluminescence].

80. Inhibition of tumor growth and metastasis in association with modification of immune response by novel organic germanium compounds.

81. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).

83. Inhibition of the enzymatic activity of ligandin by organogermanium, organolead or organotin compounds and the biliary excretion of sulfobromophthalein by the rat.

84. Does germanium interact with radular morphogenesis and biomineralization in the limpet Lottia gigantea?

85. Central action of sanumgerman in mice.

86. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.

87. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.

88. Effects of allyl sulfide, germanium and NaCl on the development of glutathion S-transferase P-positive rat hepatic foci initiated by diethylnitrosamine.

89. Effect of spirogermanium on V79 Chinese hamster cells.

90. Inhibitory effects of Ge-132 (carboxyethyl germanium sesquioxide) derivatives on enkephalin-degrading enzymes.

91. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.

93. Spirogermanium: effects on hematopoietic stem cells and survival of normal and tumor-bearing mice.

94. Suppression and acceleration of experimental amyloidosis in mouse model.

95. [Elemental-organic combinations in medicine].

96. Antitumor properties of organometallic metallocene complexes of tin and germanium.

97. Analgesic effect of novel organogermanium compound, GE-132.

98. [Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice].

99. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.

100. [Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].

Catalog

Books, media, physical & digital resources